HA
KITE

Havens Advisors’s Kite Pharma, Inc. KITE Stock Holding History

Havens Advisors’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-16,700
Closed -$3M – 31
2017
Q3 		$3M Buy
+16,700
New +$2.33M 2.03% 16

Havens Advisors's KITE Position: Q4 2017 in Review

Havens Advisors sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 39,700 shares — an estimated $7.14M sold.

Havens Advisors first reported a position in KITE in Q3 2017 and held it in 1 quarter. The position peaked at $7.14M in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

  • Havens Advisors reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
  • Havens Advisors sold 39,700 Kite Pharma, Inc. shares in Q4 2017, an estimated $7.14M.
  • Havens Advisors first reported a position in Kite Pharma, Inc. in Q3 2017 and held it in 1 quarter.
  • Havens Advisors's Kite Pharma, Inc. position peaked at $7.14M in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Havens Advisors's 13F filing for Q4 2017, filed 17 Jan 2018.